Results 131 to 140 of about 615,826 (248)
Objectives: The burden of allergic diseases in children and adolescents is on the rise in China. This study aimed to reveal the unique epidemiology characteristics and temporal aggregation patterns among them.
Xiangyu Yan +7 more
doaj +1 more source
Atopic outcomes at 5 years in the CORAL cohort born during the 2020 COVID‐19 lockdown
Trajectories of atopic conditions between 1y and 5y of age followed known patterns in infants born during COVID‐19 lockdown in 2020. Rates of other health outcomes except actual COVID‐19 infection all increased predictably. Abstract Background The 2020 SARS‐CoV‐2 lockdown in Ireland was among the most stringent in Europe.
Anitha Sokay +8 more
wiley +1 more source
Update on Pediatric asthma management: Recent advances
Pathophysiology of asthma: an opportunity for personalized targeted therapeutics. Abstract Asthma remains the commonest chronic pediatric respiratory disease and a major cause of childhood morbidity worldwide. Recent advances in pediatric asthma management shift the focus from symptom relief alone towards early control of airway inflammation ...
Nitin Dhochak +2 more
wiley +1 more source
Higher short‐term PM2.5 exposure was associated with greater rhinitis symptom severity in children with chronic rhinitis, with consistent findings in both allergic and nonallergic phenotypes. These results support considering ambient air pollution as an important environmental factor in pediatric rhinitis management.
Rinrada Naka +8 more
wiley +1 more source
Allergic rhinitis and genetic components: focus on Toll-like receptors (TLRs) gene polymorphism
Zhiwei Gao1, Donna C Rennie2, Ambikaipakan Senthilselvan11Department of Public Health Sciences, School of Public Health, University of Alberta, Edmonton, Alberta, Canada; 2College of Nursing and Canadian Centre for Health and Agricultural Safety ...
Ambikaipakan Senthilselvan +2 more
core
Pharmacological Tools of Allergic Rhinitis
Allergic rhinitis is an ubiquitous chronic inflammatory disorder of the nasal mucosa caused by allergens, greatly affecting patients' quality of life.
Shabu, Hibah
core
Clinical &Experimental Allergy, Volume 56, Issue 9, Page 1137-1139, September 2026.
Ellen Tameeris +4 more
wiley +1 more source
Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine
Xue Yan Wang,1 Margaret Lim-Jurado,2 Narayanan Prepageran,3 Pongsakorn Tantilipikorn,4 De Yun Wang5 1Department of Allergy, Beijing Shijitan Hospital, Capital Medical University, Beijing, People’s Republic of China; 2St Luke’s Medical Center,
Wang DY +4 more
core
The burden of allergic rhinitis and the available therapeutic options
Allergic rhinitis is an increasing burden for our society from the patients point of perspective as well as from the economics perspective. For the treatment the approach has to be separated into disease modifying and non-modifying.
Bilda, Andreas
core

